{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:37:23Z","timestamp":1790573843001,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["5 UH2 AA026212-02"],"award-info":[{"award-number":["5 UH2 AA026212-02"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000085","name":"Ontario HIV Treatment Network","doi-asserted-by":"publisher","award":["HIV Endgame Leader Award - Innovator"],"award-info":[{"award-number":["HIV Endgame Leader Award - Innovator"]}],"id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gay, bisexual, and other men-who-have-sex-with-men (GBMSM) continue to be disproportionately affected by Human Immunodeficiency Virus (HIV). Although HIV pre-exposure prophylaxis (PrEP) offers an effective means of reducing incident HIV among this population, the HIV-preventive success of oral-based PrEP is contingent upon regimen adherence. Elevated rates of alcohol-, substance use-, and mental health-related issues among GBMSM potentially hinder PrEP-taking efforts, however the evidence for this remains mixed. Accordingly, the present study entailed a comprehensive qualitative investigation to explore PrEP-prescribed GBMSM\u2019s perceptions surrounding the influence of alcohol, substance use, and mental health on PrEP adherence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PrEP-prescribed GBMSM (age\u2009\u2265\u200918\u00a0years; prescribed PrEP for\u2009\u2265\u20093\u00a0months) were recruited from two PrEP-delivery clinics in Toronto, Canada for focus groups as part of the formative phase of an alcohol-, substance use-, and mental health-focused randomized controlled intervention trial. Focus group discussions qualitatively explored perceived strengths and barriers associated with adherence to PrEP treatment; with an emphasis on alcohol, substance use, and mental health concerns. Condom use among PrEP-prescribed GBMSM within the context of these concerns was also discussed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of five focus groups involving 35 GBMSM were conducted (4\u201310\/group; mean age\u2009=\u200942.4; white\u2009=\u200971.4%). Although participants themselves generally reported successfully adhering to their PrEP regimens\u2014resulting from a strong, underlying motivation for self-care\u2014they recognized the detrimental impact that alcohol, substance use, and mental health had on adherence among their peers. In this regard, alcohol and substances were perceived as detracting from adherence only when consumption was excessive or temporally linked to PrEP dosing. Pronounced mental health issues (e.g., severe depression) were also seen as hindering adherence, although these effects were nuanced and perceived as person-dependent. Alcohol and substances were linked to condomless sex, regardless of PrEP use, and PrEP was therefore viewed as an HIV-protective \u2018safety net.\u2019<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, findings suggest that PrEP adherence can often be successfully achieved in the presence of alcohol-, substance use-, and mental health-related issues. Augmenting self-care, and addressing pronounced addictions- and mental health-related concerns, may enhance PrEP treatment among GBMSM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-14279-2","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:02:44Z","timestamp":1665140564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Perceived influence of alcohol consumption, substance use, and mental health on PrEP adherence and condom use among PrEP-prescribed gay, bisexual, and other men-who-have-sex-with-men: a qualitative investigation"],"prefix":"10.1186","volume":"22","author":[{"given":"Paul A.","family":"Shuper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thepikaa","family":"Varatharajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne","family":"Gesink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Joharchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac I.","family":"Bogoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Loutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"14279_CR1","unstructured":"UNAIDS: Global AIDS update 2019\u2014communities at the centre. Geneva: UNAIDS;\u00a02019. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019-global-AIDS-update_en.pdf. Accessed 6 Oct 2022."},{"key":"14279_CR2","unstructured":"UNAIDS: Seizing the moment: Tackling entrenched inequalities to end epidemics. Geneva: UNAIDS; 2020. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2020_global-aids-report_en.pdf. Accessed 6 Oct 2022."},{"key":"14279_CR3","unstructured":"HIV surveillance report - Diagnoses of HIV infection in the United States and Dependent Areas, 2019. Vol. 32. Centers for Disease Control and Prevention, Atlanta. 2021. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2018-updated-vol-32.pdf. Accessed 6 Oct 2022."},{"issue":"12","key":"14279_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.14745\/ccdr.v45i12a01","volume":"45","author":"N Haddad","year":"2019","unstructured":"Haddad N, Robert A, Weeks A, Popovic N, Siu W, Archibald C. HIV in Canada-surveillance report, 2018. Can Commun Dis Rep. 2019;45(12):304\u201312.","journal-title":"Can Commun Dis Rep"},{"issue":"5","key":"14279_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New Engl J Med. 2012;367(5):399\u2013410.","journal-title":"New Engl J Med"},{"issue":"27","key":"14279_CR6","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Med. 2010;363(27):2587\u201399.","journal-title":"New Engl J Med"},{"issue":"10013","key":"14279_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet"},{"issue":"23","key":"14279_CR8","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New Engl J Med. 2015;373(23):2237\u201346.","journal-title":"New Engl J Med"},{"issue":"5","key":"14279_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, Henderson FL, Pathank SR, Soud FA, Chillag KL, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New Engl J Med. 2012;367(5):423\u201334.","journal-title":"New Engl J Med"},{"issue":"151","key":"14279_CR10","doi-asserted-by":"publisher","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","volume":"4","author":"PL Anderson","year":"2012","unstructured":"Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, McMahan V, Bushman LR, Casapia M, Montoya-Herrera O, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.","journal-title":"Sci Transl Med"},{"issue":"10","key":"14279_CR11","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","volume":"61","author":"JE Volk","year":"2015","unstructured":"Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis. 2015;61(10):1601\u20133.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"14279_CR12","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1093\/cid\/ciu266","volume":"59","author":"KR Amico","year":"2014","unstructured":"Amico KR, Stirratt MJ. Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence. Clin Infect Dis. 2014;59(Suppl 1):S55\u201360.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"14279_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"14279_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. New Engl J Med. 2015;372(6):509\u201318.","journal-title":"New Engl J Med"},{"issue":"5","key":"14279_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, et al. Preexposure prophylaxis for HIV infection among African women. New Engl J Med. 2012;367(5):411\u201322.","journal-title":"New Engl J Med"},{"issue":"3","key":"14279_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/QAI.0000000000001374","volume":"75","author":"MV Sivay","year":"2017","unstructured":"Sivay MV, Li M, Piwowar-Manning E, Zhang Y, Hudelson SE, Marzinke MA, Amico RK, Redd A, Hendrix CW, Anderson PL, et al. Characterization of HIV seroconverters in a TDF\/FTC PrEP study: HPTN 067\/ADAPT. J Acquir Immune Defic Syndr. 2017;75(3):271\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"14279_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385(7):595\u2013608.","journal-title":"N Engl J Med"},{"issue":"5","key":"14279_CR18","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1521\/aeap.2020.32.5.416","volume":"32","author":"SZ Ching","year":"2020","unstructured":"Ching SZ, Wong LP, Said MAB, Lim SH. Meta-synthesis of qualitative research of Pre-exposure Prophylaxis (PrEP) adherence among men who have sex with men (MSM). AIDS Educ Prev. 2020;32(5):416\u201331.","journal-title":"AIDS Educ Prev"},{"issue":"6","key":"14279_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/09540121.2020.1778628","volume":"33","author":"A Edeza","year":"2021","unstructured":"Edeza A, Karina Santamaria E, Valente PK, Gomez A, Ogunbajo A, Biello K. Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies. AIDS Care. 2021;33(6):697\u2013705.","journal-title":"AIDS Care"},{"issue":"4","key":"14279_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/dar.12234","volume":"34","author":"T Lea","year":"2015","unstructured":"Lea T, Ryan D, Prestage G, Zablotska I, Mao L. de WJ, Holt M: Alcohol use among a community-based sample of gay men: correlates of high-risk use and implications for service provision. Drug Alcohol Rev. 2015;34(4):349\u201357.","journal-title":"Drug Alcohol Rev"},{"key":"14279_CR21","doi-asserted-by":"crossref","unstructured":"Ostrow DG, Stall R. Alcohol, Tobacco, and Drug Use among Gay and Bisexual Men. In: Wolitski RJ, Stall R, Valdiserri RO, editors. Unequal opportunity: health disparities affecting gay and bisexual men in the United States. New York: Oxford University Press; 2008. p. 121\u201358.","DOI":"10.1093\/acprof:oso\/9780195301533.003.0005"},{"issue":"5","key":"14279_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1037\/0278-6133.23.5.525","volume":"23","author":"PA Vanable","year":"2004","unstructured":"Vanable PA, McKirnan DJ, Buchbinder SP, Bartholow BN, Douglas JM Jr, Judson FN, MacQueen KM. Alcohol use and high-risk sexual behavior among men who have sex with men: the effects of consumption level and partner type. Health Psychol. 2004;23(5):525\u201332.","journal-title":"Health Psychol"},{"issue":"4","key":"14279_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10461-007-9354-0","volume":"13","author":"SE Woolf","year":"2009","unstructured":"Woolf SE, Maisto SA. Alcohol use and risk of HIV infection among men who have sex with men. AIDS Behav. 2009;13(4):757\u201382.","journal-title":"AIDS Behav"},{"key":"14279_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2014.12.023","volume":"148","author":"BD Marshall","year":"2015","unstructured":"Marshall BD, Operario D, Bryant KJ, Cook RL, Edelman EJ, Gaither JR, Gordon AJ, Kahler CW, Maisto SA, McGinnis KA, et al. Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans. Drug Alcohol Depend. 2015;148:69\u201376.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"14279_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/acer.12631","volume":"39","author":"BD Marshall","year":"2015","unstructured":"Marshall BD, Shoveller JA, Kahler CW, Koblin BA, Mayer KH, Mimiaga MJ, van den Berg JJ, Zaller ND, Operario D. Heavy drinking trajectories among men who have sex with men: a longitudinal, group-based analysis. Alcohol Clin Exp Res. 2015;39(2):380\u20139.","journal-title":"Alcohol Clin Exp Res"},{"key":"14279_CR26","doi-asserted-by":"crossref","unstructured":"Hatzenbuehler ML. How does sexual minority stigma \u201cget under the skin\u201d? a psychological mediation framework. Psychol Bull. 2009;135(5):707\u201330.","DOI":"10.1037\/a0016441"},{"issue":"2","key":"14279_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/QAI.0b013e3181b18b6e","volume":"52","author":"CS Hendershot","year":"2009","unstructured":"Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180\u2013202.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"14279_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1037\/a0012664","volume":"27","author":"JT Parsons","year":"2008","unstructured":"Parsons JT, Rosof E, Mustanski B. The temporal relationship between alcohol consumption and HIV-medication adherence: a multilevel model of direct and moderating effects. Health Psychol. 2008;27(5):628\u201337.","journal-title":"Health Psychol"},{"issue":"9","key":"14279_CR29","doi-asserted-by":"publisher","first-page":"e1001511","DOI":"10.1371\/journal.pmed.1001511","volume":"10","author":"JE Haberer","year":"2013","unstructured":"Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, et al. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med. 2013;10(9):e1001511.","journal-title":"PLoS Med"},{"issue":"5","key":"14279_CR30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s10461-014-0958-x","volume":"19","author":"PM Mugo","year":"2015","unstructured":"Mugo PM, Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, Bangsberg DR, Priddy FH, Haberer JE. Understanding adherence to daily and intermittent regimens of oral HIV pre-exposure prophylaxis among men who have sex with men in Kenya. AIDS Behav. 2015;19(5):794\u2013801.","journal-title":"AIDS Behav"},{"issue":"6","key":"14279_CR31","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s10461-012-0317-8","volume":"17","author":"EM van der Elst","year":"2013","unstructured":"van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162\u201372.","journal-title":"AIDS Behav"},{"key":"14279_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3389\/fphar.2019.00785","volume":"10","author":"S Mallayasamy","year":"2019","unstructured":"Mallayasamy S, Chaturvedula A, Fossler MJ, Sale ME, Hendrix CW, Haberer JE. Assessment of demographic and socio-behavioral factors on adherence to HIV pre-exposure prophylaxis using a markov modeling approach. Front Pharmacol. 2019;10:785.","journal-title":"Front Pharmacol"},{"issue":"1","key":"14279_CR33","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1186\/s12889-020-09883-z","volume":"20","author":"PA Shuper","year":"2020","unstructured":"Shuper PA, Joharchi N, Bogoch II, Loutfy M, Crouzat F, El-Helou P, Knox DC, Woodward K, Rehm J. Alcohol consumption, substance use, and depression in relation to HIV Pre-Exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men. BMC Public Health. 2020;20(1):1782.","journal-title":"BMC Public Health"},{"issue":"6","key":"14279_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11121-017-0799-8","volume":"18","author":"ED Storholm","year":"2017","unstructured":"Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737\u201347.","journal-title":"Prev Sci"},{"issue":"2","key":"14279_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09540121.2017.1360992","volume":"30","author":"EF Closson","year":"2018","unstructured":"Closson EF, Mitty JA, Malone J, Mayer KH, Mimiaga MJ. Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study. AIDS Care. 2018;30(2):191\u20138.","journal-title":"AIDS Care"},{"issue":"5","key":"14279_CR36","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10461-018-2309-9","volume":"23","author":"C Grov","year":"2019","unstructured":"Grov C, Rendina HJ, John SA, Parsons JT. Determining the roles that club drugs, marijuana, and heavy drinking play in PrEP medication adherence among gay and bisexual men: implications for treatment and research. AIDS Behav. 2019;23(5):1277\u201386.","journal-title":"AIDS Behav"},{"issue":"7","key":"14279_CR37","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1093\/cid\/ciz1093","volume":"71","author":"M Hoenigl","year":"2019","unstructured":"Hoenigl M, Little SJ, Grelotti D, Skaathun B, Wagner GA, Weibel N, Stockman JK, Smith DM. Grindr users take more risks, but are more open to human immunodeficiency virus (HIV) pre-exposure prophylaxis: could this dating app provide a platform for hiv prevention outreach? Clin Infect Dis. 2019;71(7):e135\u201340.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"14279_CR38","doi-asserted-by":"publisher","first-page":"e25103","DOI":"10.1002\/jia2.25103","volume":"21","author":"JC Hojilla","year":"2018","unstructured":"Hojilla JC, Vlahov D, Glidden DV, Amico KR, Mehrotra M, Hance R, Grant RM, Carrico AW. Skating on thin ice: stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis. J Int AIDS Soc. 2018;21(3):e25103.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"14279_CR39","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/QAI.0000000000002131","volume":"82","author":"TH Holtz","year":"2019","unstructured":"Holtz TH, Chitwarakorn A, Hughes JP, Curlin ME, Varangrat A, Li M, Amico KR, Mock PA, Grant RM. HPTN 067\/ADAPT: correlates of sex-related pre-exposure prophylaxis adherence, Thai men who have sex with men, and transgender women, 2012\u20132013. J Acquir Immune Defic Syndr. 2019;82(2):e18\u201326.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"14279_CR40","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/infdis\/jiy368","volume":"218","author":"EC Pasipanodya","year":"2018","unstructured":"Pasipanodya EC, Jain S, Sun X, Blumenthal J, Ellorin E, Corado K, Dube MP, Daar ES, Morris SR, Moore DJ. Trajectories and predictors of longitudinal preexposure prophylaxis adherence among men who have sex with men. J Infect Dis. 2018;218(10):1551\u20139.","journal-title":"J Infect Dis"},{"issue":"4","key":"14279_CR41","doi-asserted-by":"publisher","first-page":"e25472","DOI":"10.1002\/jia2.25472","volume":"23","author":"MA Spinelli","year":"2020","unstructured":"Spinelli MA, Laborde N, Kinley P, Whitacre R, Scott HM, Walker N, Liu AY, Gandhi M, Buchbinder SP. Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States. J Int AIDS Soc. 2020;23(4):e25472.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"14279_CR42","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1007\/s10461-020-02901-6","volume":"24","author":"PW Colson","year":"2020","unstructured":"Colson PW, Franks J, Wu Y, Winterhalter FS, Knox J, Ortega H, El-Sadr WM, Hirsch-Moverman Y. Adherence to pre-exposure prophylaxis in black men who have sex with men and transgender women in a community setting in Harlem. NY AIDS Behav. 2020;24(12):3436\u201355.","journal-title":"NY AIDS Behav"},{"issue":"6","key":"14279_CR43","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s10461-019-02716-0","volume":"24","author":"J Velloza","year":"2020","unstructured":"Velloza J, Kemp CG, Aunon FM, Ramaiya MK, Creegan E, Simoni JM. Alcohol use and antiretroviral therapy non-adherence among adults living with HIV\/AIDS in Sub-Saharan Africa: a systematic review and meta-analysis. AIDS Behav. 2020;24(6):1727\u201342.","journal-title":"AIDS Behav"},{"key":"14279_CR44","doi-asserted-by":"crossref","unstructured":"O\u2019Halloran C, Rice B, White E, Desai M, Dunn DT, McCormack S, Sullivan AK, White D, McOwan A, Gafos M. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants. Int J Drug Policy. 2019;74:246\u201354.","DOI":"10.1016\/j.drugpo.2019.10.007"},{"issue":"2","key":"14279_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/QAI.0000000000002128","volume":"82","author":"J Velloza","year":"2019","unstructured":"Velloza J, Bacchetti P, Hendrix CW, Murnane P, Hughes JP, Li M, Curlin ME, Holtz TH, Mannheimer S, Marzinke MA, et al. Short- and long-term pharmacologic measures of HIV pre-exposure prophylaxis use among high-risk men who have sex with men in HPTN 067\/ADAPT. J Acquir Immune Defic Syndr. 2019;82(2):149\u201358.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"14279_CR46","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/QAI.0000000000002037","volume":"81","author":"ML Mehrotra","year":"2019","unstructured":"Mehrotra ML, Westreich D, McMahan VM, Glymour MM, Geng E, Grant RM, Glidden DV. Baseline characteristics explain differences in effectiveness of randomization to daily oral TDF\/FTC PrEP between transgender women and cisgender men who have sex with men in the iPrEx trial. J Acquir Immune Defic Syndr. 2019;81(3):e94\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"14279_CR47","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10461-015-1055-5","volume":"20","author":"JC Hojilla","year":"2016","unstructured":"Hojilla JC, Koester KA, Cohen SE, Buchbinder S, Ladzekpo D, Matheson T, Liu AY. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461\u20139.","journal-title":"AIDS Behav"},{"key":"14279_CR48","unstructured":"IBM Corp. IBM SPSS Statistics for windows. Version 26.0 edition. Armonk: IBM Corp; 2019."},{"issue":"2","key":"14279_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"14279_CR50","unstructured":"NVivo QSR Ltd. NVivo qualitative data analysis software Version 12. Burlington: QSR International Pty Ltd;\u00a02018."},{"key":"14279_CR51","unstructured":"Coffey A, Atkinson P. Making sense of qualitative data: complementary research strategies. Thousand Oaks: Sage Publications, Inc; 1996."},{"issue":"3","key":"14279_CR52","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijnurstu.2011.09.012","volume":"49","author":"BD de Casterl\u00e9","year":"2012","unstructured":"de Casterl\u00e9 BD, Gastmans C, Bryon E, Denier Y. QUAGOL: a guide for qualitative data analysis. Int J Nurs Stud. 2012;49(3):360\u201371.","journal-title":"Int J Nurs Stud"},{"key":"14279_CR53","doi-asserted-by":"publisher","first-page":"108875","DOI":"10.1016\/j.drugalcdep.2021.108875","volume":"226","author":"JL Flores Anato","year":"2021","unstructured":"Flores Anato JL, Panagiotoglou D, Greenwald ZR, Trottier C, Vaziri M, Thomas R, Maheu-Giroux M. Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montreal, Canada (2013\u20132020). Drug Alcohol Depend. 2021;226:108875.","journal-title":"Drug Alcohol Depend"},{"key":"14279_CR54","doi-asserted-by":"publisher","first-page":"103630","DOI":"10.1016\/j.drugpo.2022.103630","volume":"103","author":"S Maxwell","year":"2022","unstructured":"Maxwell S, Shahmanesh M, Gafos M. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: a qualitative study. Int J Drug Policy. 2022;103:103630.","journal-title":"Int J Drug Policy"},{"key":"14279_CR55","doi-asserted-by":"crossref","unstructured":"Chou FY, Holzemer WL. Linking HIV\/AIDS clients\u2019 self-care with outcomes. J Assoc Nurses AIDS Care. 2004;15(4):58\u201367.","DOI":"10.1177\/1055329003255592"},{"issue":"12","key":"14279_CR56","doi-asserted-by":"publisher","first-page":"e0205919","DOI":"10.1371\/journal.pone.0205919","volume":"13","author":"P Nhassengo","year":"2018","unstructured":"Nhassengo P, Cataldo F, Magaco A, Hoffman RM, Nerua L, Saide M, Cuco R, Hoek R, Mbofana F, Couto A, et al. Barriers and facilitators to the uptake of test and treat in Mozambique: a qualitative study on patient and provider perceptions. PLoS ONE. 2018;13(12):e0205919.","journal-title":"PLoS ONE"},{"issue":"12","key":"14279_CR57","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1089\/apc.2013.0330","volume":"28","author":"GW Harper","year":"2014","unstructured":"Harper GW, Bruce D, Hosek SG, Fernandez MI, Rood BA. Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention. AIDS Patient Care STDS. 2014;28(12):666\u201376.","journal-title":"AIDS Patient Care STDS"},{"issue":"11","key":"14279_CR58","doi-asserted-by":"publisher","first-page":"e27533","DOI":"10.1371\/journal.pone.0027533","volume":"6","author":"P Saberi","year":"2011","unstructured":"Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS ONE. 2011;6(11):e27533.","journal-title":"PLoS ONE"},{"issue":"1","key":"14279_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12160-010-9230-4","volume":"41","author":"MO Johnson","year":"2011","unstructured":"Johnson MO, Dilworth SE, Taylor JM, Neilands TB. Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV. Ann Behav Med. 2011;41(1):83\u201391.","journal-title":"Ann Behav Med"},{"issue":"10","key":"14279_CR60","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/09540120902803158","volume":"21","author":"D Swendeman","year":"2009","unstructured":"Swendeman D, Ingram BL, Rotheram-Borus MJ. Common elements in self-management of HIV and other chronic illnesses: an integrative framework. AIDS Care. 2009;21(10):1321\u201334.","journal-title":"AIDS Care"},{"issue":"Suppl 2","key":"14279_CR61","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10461-017-1886-3","volume":"21","author":"LAJ Scott-Sheldon","year":"2017","unstructured":"Scott-Sheldon LAJ, Carey KB, Johnson BT, Carey MP. Behavioral interventions targeting alcohol use among people living with HIV\/AIDS: a systematic review and meta-analysis. AIDS Behav. 2017;21(Suppl 2):126\u201343.","journal-title":"AIDS Behav"},{"issue":"3","key":"14279_CR62","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12160-013-9559-6","volume":"47","author":"NL Sin","year":"2014","unstructured":"Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259\u201369.","journal-title":"Ann Behav Med"},{"issue":"7","key":"14279_CR63","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s10461-015-1082-2","volume":"20","author":"PA Defechereux","year":"2016","unstructured":"Defechereux PA, Mehrotra M, Liu AY, McMahan VM, Glidden DV, Mayer KH, Vargas L, Amico KR, Chodacki P, Fernandez T. Depression and oral FTC\/TDF pre-exposure prophylaxis (PrEP) among men and transgender women who have sex with men (MSM\/TGW). AIDS Behav. 2016;20(7):1478\u201388.","journal-title":"AIDS Behav"},{"issue":"11","key":"14279_CR64","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/QAD.0000000000000647","volume":"29","author":"JE Haberer","year":"2015","unstructured":"Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P, et al. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015;29(11):1277\u201385.","journal-title":"AIDS"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-14279-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14279-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T11:03:04Z","timestamp":1665140584000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-14279-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14279"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-14279-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. All participants provided informed written consent. Procedures were approved by Research Ethics Boards at the Center for Addiction and Mental Health (Protocol# 101\u20132018) and the University Health Network (Protocol# 18\u20135014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1875"}}